The KEAP1–NRF2 System in Cancer

Itoh, 1997, An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements, Biochem Biophys Res Commun, 236, 313, 10.1006/bbrc.1997.6943

McMahon, 2001, The Cap’n’Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes, Cancer Res, 61, 3299

Kobayashi, 2004, Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2, Mol Cell Biol, 24, 7130, 10.1128/MCB.24.16.7130-7139.2004

Tong, 2006, Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model, Mol Cell Biol, 26, 2887, 10.1128/MCB.26.8.2887-2900.2006

Kim, 2016, NRF2, a key regulator of antioxidants with two faces towards cancer, Oxid Med Cell Longev, 2016, 2746457, 10.1155/2016/2746457

Iso, 2016, Absolute amounts and status of the Nrf2-Keap1-Cul3 complex within cells, Mol Cell Biol, 36, 3100, 10.1128/MCB.00389-16

Itoh, 2001, Nrf2 activation by electrophiles is mediated by the inhibition of proteasomal degradation of Nrf2 protein in activated macrophages, FASEB J, 15, A899, 10.1128/MCB.26.1.221-229.2006

McMahon, 2003, Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression, J Biol Chem, 278, 21592, 10.1074/jbc.M300931200

Zhang, 2004, Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex, Mol Cell Biol, 24, 10941, 10.1128/MCB.24.24.10941-10953.2004

Fukutomi, 2014, Kinetic, thermodynamic, and structural characterizations of the association between Nrf2-DLGex degron and Keap1, Mol Cell Biol, 34, 832, 10.1128/MCB.01191-13

Itoh, 1999, Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain, Genes Dev, 13, 76, 10.1101/gad.13.1.76

Dinkova-Kostova, 2005, Keap1, the sensor for electrophiles and oxidants that regulates the phase 2 response, is a zinc metalloprotein, Biochemistry, 44, 6889, 10.1021/bi047434h

Zhang, 2003, Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress, Mol Cell Biol, 23, 8137, 10.1128/MCB.23.22.8137-8151.2003

Takaya, 2012, Validation of the multiple sensor mechanism of the Keap1-Nrf2 system, Free Radic Biol Med, 53, 817, 10.1016/j.freeradbiomed.2012.06.023

Saito, 2015, Characterizations of three major cysteine sensors of Keap1 in stress response, Mol Cell Biol, 36, 271, 10.1128/MCB.00868-15

Eggler, 2007, Identification of the highly reactive cysteine 151 in the chemopreventive agent-sensor Keap1 protein is method-dependent, Chem Res Toxicol, 20, 1878, 10.1021/tx700217c

Taguchi, 2011, Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution, Genes Cells, 16, 123, 10.1111/j.1365-2443.2010.01473.x

Ishii, 2000, Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages, J Biol Chem, 275, 16023, 10.1074/jbc.275.21.16023

Rachakonda, 2008, Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3, Chem Res Toxicol, 21, 705, 10.1021/tx700302s

Abiko, 2011, Participation of covalent modification of Keap1 in the activation of Nrf2 by tert-butylbenzoquinone, an electrophilic metabolite of butylated hydroxyanisole, Toxicol Appl Pharmacol, 255, 32, 10.1016/j.taap.2011.05.013

Kobayashi, 2006, Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1, Mol Cell Biol, 26, 221, 10.1128/MCB.26.1.221-229.2006

Watai, 2007, Subcellular localization and cytoplasmic complex status of endogenous Keap1, Genes Cells, 12, 1163, 10.1111/j.1365-2443.2007.01118.x

Kang, 2004, Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes, Proc Natl Acad Sci U S A, 101, 2046, 10.1073/pnas.0308347100

Rada, 2012, Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/beta-TrCP axis, Mol Cell Biol, 32, 3486, 10.1128/MCB.00180-12

Chowdhry, 2013, Nrf2 is controlled by two distinct beta-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity, Oncogene, 32, 3765, 10.1038/onc.2012.388

Mitsuishi, 2012, Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming, Cancer Cell, 22, 66, 10.1016/j.ccr.2012.05.016

Taguchi, 2014, Nrf2 enhances cholangiocyte expansion in Pten-deficient livers, Mol Cell Biol, 34, 900, 10.1128/MCB.01384-13

Cheng, 2013, Regulation of the Nrf2 antioxidant pathway by microRNAs: new players in micromanaging redox homeostasis, Free Radic Biol Med, 64, 4, 10.1016/j.freeradbiomed.2013.07.025

Yang, 2011, MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism, Breast Cancer Res Treat, 129, 983, 10.1007/s10549-011-1604-1

Eades, 2011, miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells, J Biol Chem, 286, 40725, 10.1074/jbc.M111.275495

Singh, 2013, Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis, J Clin Invest, 123, 2921, 10.1172/JCI66353

Rushmore, 1990, Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants, J Biol Chem, 265, 14648, 10.1016/S0021-9258(18)77351-1

Friling, 1990, Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element, Proc Natl Acad Sci U S A, 87, 6258, 10.1073/pnas.87.16.6258

Hirotsu, 2012, Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks, Nucleic Acids Res, 40, 10228, 10.1093/nar/gks827

Mignotte, 1990, The extinction of erythroid genes after tetradecanoylphorbol acetate treatment of erythroleukemic cells correlates with down-regulation of the tissue-specific factors NF-E1 and NF-E2, J Biol Chem, 265, 22090, 10.1016/S0021-9258(18)45673-6

Sykiotis, 2008, Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila, Dev Cell, 14, 76, 10.1016/j.devcel.2007.12.002

Otsuki, 2016, Unique cistrome defined as CsMBE is strictly required for Nrf2-sMaf heterodimer function in cytoprotection, Free Radic Biol Med, 91, 45, 10.1016/j.freeradbiomed.2015.12.005

Malhotra, 2010, Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis, Nucleic Acids Res, 38, 5718, 10.1093/nar/gkq212

Chorley, 2012, Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha, Nucleic Acids Res, 40, 7416, 10.1093/nar/gks409

Suzuki, 2013, Toward clinical application of the Keap1-Nrf2 pathway, Trends Pharmacol Sci, 34, 340, 10.1016/j.tips.2013.04.005

Padmanabhan, 2006, Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer, Mol Cell, 21, 689, 10.1016/j.molcel.2006.01.013

Ohta, 2008, Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth, Cancer Res, 68, 1303, 10.1158/0008-5472.CAN-07-5003

Leinonen, 2015, Dysregulation of the Keap1-Nrf2 pathway in cancer, Biochem Soc Trans, 43, 645, 10.1042/BST20150048

Ramos-Gomez, 2003, Interactive effects of nrf2 genotype and oltipraz on benzo[a]pyrene-DNA adducts and tumor yield in mice, Carcinogenesis, 24, 461, 10.1093/carcin/24.3.461

Solt, 1977, Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis, Am J Pathol, 88, 595

Kartner, 1983, Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein, Cancer Res, 43, 4413

Singh, 2006, Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer, PLoS Med, 3, e420, 10.1371/journal.pmed.0030420

Ooi, 2013, CUL3 and NRF2 mutations confer an NRF2 activation phenotype in a sporadic form of papillary renal cell carcinoma, Cancer Res, 73, 2044, 10.1158/0008-5472.CAN-12-3227

Menegon, 2016, The dual roles of NRF2 in cancer, Trends Mol Med, 22, 578, 10.1016/j.molmed.2016.05.002

Wang, 2008, Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues, Biochem Biophys Res Commun, 373, 151, 10.1016/j.bbrc.2008.06.004

Komatsu, 2010, The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1, Nat Cell Biol, 12, 213, 10.1038/ncb2021

Chen, 2009, Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response, Mol Cell, 34, 663, 10.1016/j.molcel.2009.04.029

Adam, 2011, Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling, Cancer Cell, 20, 524, 10.1016/j.ccr.2011.09.006

Ooi, 2011, An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma, Cancer Cell, 20, 511, 10.1016/j.ccr.2011.08.024

Taguchi, 2008, Redox cycling of 9,10-phenanthraquinone to cause oxidative stress is terminated through its monoglucuronide conjugation in human pulmonary epithelial A549 cells, Free Radic Biol Med, 44, 1645, 10.1016/j.freeradbiomed.2008.01.024

Shibata, 2011, NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer, Neoplasia, 13, 864, 10.1593/neo.11750

Li, 2013, SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer, Cancer Cell, 24, 738, 10.1016/j.ccr.2013.10.025

Probst, 2015, Cancer cell growth is differentially affected by constitutive activation of NRF2 by KEAP1 deletion and pharmacological activation of NRF2 by the synthetic triterpenoid, RTA 405, PLoS One, 10, e0135257, 10.1371/journal.pone.0135257

Hong, 2010, Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells, Pancreas, 39, 463, 10.1097/MPA.0b013e3181c31314

Arlt, 2013, Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity, Oncogene, 32, 4825, 10.1038/onc.2012.493

Lister, 2011, Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy, Mol Cancer, 10, 37, 10.1186/1476-4598-10-37

Ichimura, 2013, Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy, Mol Cell, 51, 618, 10.1016/j.molcel.2013.08.003

2012, Comprehensive genomic characterization of squamous cell lung cancers, Nature, 489, 519, 10.1038/nature11404

Schulze, 2015, Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets, Nat Genet, 47, 505, 10.1038/ng.3252

Lee, 2003, Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis, J Biol Chem, 278, 12029, 10.1074/jbc.M211558200

Wu, 2011, Beneficial role of Nrf2 in regulating NADPH generation and consumption, Toxicol Sci, 123, 590, 10.1093/toxsci/kfr183

Saito, 2016, p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming, Nat Commun, 7, 12030, 10.1038/ncomms12030

Liu, 2015, Hepatitis B virus stimulates G6PD expression through HBx-mediated Nrf2 activation, Cell Death Dis, 6, e1980, 10.1038/cddis.2015.322

Zhang, 1992, A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure, Proc Natl Acad Sci U S A, 89, 2399, 10.1073/pnas.89.6.2399

Balogun, 2003, Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element, Biochem J, 371, 887, 10.1042/bj20021619

Satoh, 2008, Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1, J Neurochem, 104, 1116, 10.1111/j.1471-4159.2007.05039.x

Krajka-Kuzniak, 2016, The Nrf2-ARE signaling pathway: an update on its regulation and possible role in cancer prevention and treatment, Pharmacol Rep, 69, 393, 10.1016/j.pharep.2016.12.011

Zhu, 2016, An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy, Free Radic Biol Med, 99, 544, 10.1016/j.freeradbiomed.2016.09.010

Lee, 1982, Antitumor agents XLV: bisbrusatolyl and brusatolyl esters and related compounds as novel potent antileukemic agents, J Pharm Sci, 71, 338, 10.1002/jps.2600710320

Willingham, 1981, Mechanism of eukaryotic protein synthesis inhibition by brusatol, Biochim Biophys Acta, 654, 169, 10.1016/0005-2787(81)90168-4

Hall, 1982, Antitumor agents XLVI: in vitro effects of esters of brusatol, bisbrusatol, and related compounds on nucleic acid and protein synthesis of P-388 lymphocytic leukemia cells, J Pharm Sci, 71, 345, 10.1002/jps.2600710229

Liou, 1982, Antitumor agents XLVIII: structure-activity relationships of quassinoids as in vitro protein synthesis inhibitors of P-388 lymphocytic leukemia tumor cell metabolism, J Pharm Sci, 71, 430, 10.1002/jps.2600711208

Ren, 2011, Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism, Proc Natl Acad Sci U S A, 108, 1433, 10.1073/pnas.1014275108

Vartanian, 2016, Application of mass spectrometry profiling to establish brusatol as an inhibitor of global protein synthesis, Mol Cell Proteomics, 15, 1220, 10.1074/mcp.M115.055509

Singh, 2016, Small molecule inhibitor of NRF2 selectively intervenes therapeutic resistance in KEAP1-deficient NSCLC tumors, ACS Chem Biol, 11, 3214, 10.1021/acschembio.6b00651

Coatney, 1950, Studies in human malaria. XXV. Trial of febrifugine, an alkaloid obtained from Dichroa febrifuga lour., against the Chesson strain of Plasmodium vivax, J Natl Malar Soc, 9, 183

Pines, 1997, Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis, J Hepatol, 27, 391, 10.1016/S0168-8278(97)80186-9

Keller, 2012, Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase, Nat Chem Biol, 8, 311, 10.1038/nchembio.790

Elkin, 1999, Inhibition of bladder carcinoma angiogenesis, stromal support, and tumor growth by halofuginone, Cancer Res, 59, 4111

Pines, 2003, Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma, Biol Blood Marrow Transplant, 9, 417, 10.1016/S1083-8791(03)00151-4

Nevo, 2010, Fibrosis inhibition and muscle histopathology improvement in laminin-alpha2-deficient mice, Muscle Nerve, 42, 218, 10.1002/mus.21706

Tsuchida, 2016, Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation, Free Radic Biol Med, 103, 236, 10.1016/j.freeradbiomed.2016.12.041

Gao, 2013, Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway, Chem Biol Interact, 206, 100, 10.1016/j.cbi.2013.08.008

Tang, 2011, Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs, Free Radic Biol Med, 50, 1599, 10.1016/j.freeradbiomed.2011.03.008

Johnson, 2014, Complete protection against aflatoxin B1-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold, Cancer Prev Res (Phila), 7, 658, 10.1158/1940-6207.CAPR-13-0430

Iida, 2004, Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis, Cancer Res, 64, 6424, 10.1158/0008-5472.CAN-04-1906

Kelloff, 1994, Clinical development plan: oltipraz, J Cell Biochem Suppl, 20, 205

Kensler, 1995, Oltipraz: clinical opportunities for cancer chemoprevention. p, J Cell Biochem Suppl, 22, 101, 10.1002/jcb.240590813

Dinkova-Kostova, 2002, Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants, Proc Natl Acad Sci U S A, 99, 11908, 10.1073/pnas.172398899

Kensler, 2005, Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People’s Republic of China, Cancer Epidemiol Biomarkers Prev, 14, 2605, 10.1158/1055-9965.EPI-05-0368

Kowalik, 2016, Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis, Oncotarget, 7, 32375, 10.18632/oncotarget.8632